Nephros, Inc. (NEPH)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 18,789,000 32.7%
- Net income
- 1,194,000 1513.5%
- Gross profit
- 11,625,000
- Operating income
- 1,146,000
- Earnings per share
- 0.11 1000%
- R&D expense
- 1,339,000
Growth and profitability
- Gross margin
- 61.87
- Operating margin
- 6.10
- Net margin
- 6.35
- Return on equity
- 11.70
- Return on assets
- 8.75
Balance sheet
- Total assets
- 13,641,000
- Total liabilities
- 3,439,000
- Shareholders' equity
- 10,202,000
- Cash and equivalents
- 5,400,000
- Current ratio
- 4.06
Cash flow and ratios
- Operating cash flow
- 1,645,000
Shareholder returns
- Shares outstanding
- 10,870,004
- Book value per share
- 0.94
Company information
- Headquarters
- South Orange, NJ
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
Nephros, Inc. trades on NASDAQ under the ticker symbol NEPH. This page brings together its price chart, company profile, key financial figures and technical indicators.